Trials / Completed
CompletedNCT01931748
A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome
Study of Non-inferiority UNCNT Versus MELSMON in Female With Menopausal Syndrome: Randomized Confirmatory Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Unimed Pharmaceuticals · Industry
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose of this study is to evaluate in a randomized, double-blind, Parallel, Non-inferiority, Multicenter, the efficacy and safety of UNCNT in comparison to the active comparator of MELSMON in female having menopausal syndrome. Patients will be allocated randomly to receive either UNCNT or MELSMON. Through the injection of UNCNT to female having menopausal disorder, efficacy in the improvement of the menopausal symptoms by Kupperman index is to be evaluated and compared with MELSMON.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MELSMON | |
| DRUG | UNCNT |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-08-29
- Last updated
- 2014-05-08
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01931748. Inclusion in this directory is not an endorsement.